LawPlayer
My bookmarks
Source

Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

Delegated Regulation (EU) 2024/1401 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Delegated Regulation (EU) 2022/2104 is amended as follows: (1) Annex I is amended as follows: (a) table B is replaced by the table set out in Annex I to this Regulation; (b) its Appendix is deleted; (2) Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I ‘B.    Purity characteristics Category Fatty acid composition  ( 1 ) Total transoleic isomers (%) Total trans- linoleic + trans-linolenic isomers (%) Stigmasta- dienes (mg/kg)  ( 2 ) ΔΕCN42 2-glyceryl monopalmitate (%) Myristic (%) Linolenic (%) Arachidic (%) Eicosenoic (%) Behenic (%) Lignoceric (%) 1. Extra virgin olive oil ≤ 0,03 ≤ 1,00  ( 3 ) ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,05 ≤ 0,05 ≤ 0,05 ≤ |0,20 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,0 if total palmitic acid % > 14,00 % 2. Virgin olive oil ≤ 0,03 ≤ 1,00  ( 3 ) ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,05 ≤ 0,05 ≤ 0,05 ≤ |0,20 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,0 if total palmitic acid % > 14,00 % 3. Lampante olive oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,10 ≤ 0,10 ≤ 0,50 ≤ |0,30 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,1 if total palmitic acid % > 14,00 % 4. Refined olive oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,20 ≤ 0,30 — ≤ |0,30 | ≤ 0,9 if total palmitic acid % ≤ 14,00 % ≤ 1,1 if total palmitic acid% > 14,00 % 5. Olive oil composed of refined olive oil and virgin olive oils ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,20 ≤ 0,20 ≤ 0,20 ≤ 0,30 — ≤ |0,30 | ≤ 0,9 if total palmitic acid% ≤ 14,00 % ≤ 1,0 if total palmitic acid% > 14,00 % 6. Crude olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,20 ≤ 0,10 — ≤ |0,60 | ≤ 1,4 7. Refined olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,40 ≤ 0,35 — ≤ |0,50 | ≤ 1,4 8. Olive-pomace oil ≤ 0,03 ≤ 1,00 ≤ 0,60 ≤ 0,50 ≤ 0,30 ≤ 0,20 ≤ 0,40 ≤ 0,35 — ≤ |0,50 | ≤ 1,2 Table B continued Category Sterols composition Total sterols (mg/kg) Erythrodiol and uvaol (**) (%) Waxes (**) (mg/kg) Chole-sterol (%) Brassica-sterol (%) Campe-sterol(%) Stigmasterol (%) Apparent β–sito-sterol  ( 4 ) (%) Δ-7-stigma-stenol (%) 1. Extra virgin olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0  ( 5 ) < Camp. ≥ 93,0 ≤ 0,5  ( 6 ) ≥ 1 000 ≤ 4,5 C42 + C44 + C46 ≤ 150 2. Virgin olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0  ( 5 ) < Camp. ≥ 93,0 ≤ 0,5  ( 6 ) ≥ 1 000 ≤ 4,5 C42 + C44 + C46 ≤ 150 3. Lampante olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0 — ≥ 93,0 ≤ 0,5  ( 7 ) ≥ 1 000 ≤ 4,5  ( 8 ) C40 + C42 + C44 + C46 ≤ 300  ( 8 ) 4. Refined olive oil ≤ 0,5 ≤ 0,1 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 9 ) ≥ 1 000 ≤ 4,5  ( 10 ) C40 + C42 + C44 + C46 ≤ 350 5. Olive oil composed of refined olive oil and virgin olive oils ≤ 0,5 ≤ 0,1 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 9 ) ≥ 1 000 ≤ 4,5 C40 + C42 + C44 + C46 ≤ 350 6. Crude olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 — ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 2 500 > 4,5  ( 12 ) C40 + C42 + C44 + C46 > 350  ( 12 ) 7. Refined olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 1 800 > 4,5 C40 + C42 + C44 + C46 > 350 8. Olive-pomace oil ≤ 0,5 ≤ 0,2 ≤ 4,0 < Camp. ≥ 93,0 ≤ 0,5  ( 11 ) ≥ 1 600 > 4,5 C40 + C42 + C44 + C46 > 350 Notes: (a) The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4. (b) If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation. (c) For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category. (d) If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’ ( 1 )   Other fatty acids content (%): palmitic: 7,00-20,00; palmitoleic: 0,30-3,50; heptadecanoic: ≤ 0,40; heptadecenoic ≤ 0,60; stearic: 0,50-5,00; oleic: 55,00-85,00; linoleic: 2,50-21,00. ( 2 )   Total isomers which could (or could not) be separated by capillary column. ( 3 )   When the linolenic acid is more than 1,00 but less than or equal 1,40, the ratio apparent β-sitosterol/campesterol has to be greater than or equal to 24. ( 4 )   Apparent β-sitosterol: Δ-5,23-stigmastadienol+clerosterol+ β-sitosterol+sitostanol+ Δ-5-avenasterol+ Δ-5,24-stigmastadienol. ( 5 )   An extra virgin or virgin olive oil that exhibits 4,0 < campesterol % ≤ 4,5 is authentic provided that stigmasterol ≤ 1,4 %, Δ-7-stigmastenol ≤ 0,3 % and all other parameters lie within the limits fixed in this Regulation. ( 6 )   An extra virgin or virgin olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔECN42 ≤|0,10| and all other parameters lie within the limits fixed in this Regulation. ( 7 )   A lampante olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15|, stigmastadienes ≤ 0,30 mg/kg and all other parameters lie within the limits fixed in this Regulation. ( 8 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be lampante olive oil if the total aliphatic alcohol content is less than or equal to 350 mg/kg or if the erythrodiol and uvaol content is less than or equal to 3,5 %. ( 9 )   A refined olive oil or olive oil composed of refined olive oil and virgin olive oils that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15| and all other parameters lie within the limits fixed in this Regulation. ( 10 )   Oils with an erythrodiol + uvaol content of between 4,5 and 6 % must have an erythrodiol content of less than or equal to 75 mg/kg. ( 11 )   A crude olive-pomace oil or refined olive-pomace oil or olive-pomace oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that stigmasterol ≤ 1,4 %, ΔECN42 ≤ |0,40| and all other parameters lie within the limits fixed in this Regulation. ( 12 )   Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be crude olive-pomace oil if the total aliphatic alcohol content is above 350 mg/kg and if the erythrodiol and uvaol content is greater than 3,5 %.

ANNEX IISupplementary provisions

Open ↗

ANNEX II ‘ANNEX III CORRELATION TABLE Implementing Regulation (EU) No 29/2012 Regulation (EEC) No 2568/91 This Regulation Implementing Regulation (EU) 2022/2105 — — Article 1, point (a)   — —   Article 1 — —   Article 2(2) Article 1(1)   Article 1, point (b), and Article 1(2)   Article 1(2)   Article 1, point (b)   Article 2, first paragraph   Article 4(1)   Article 2, second paragraph   Article 4(2)   Article 3, first paragraph   Article 6(1)   Article 3, second paragraph, points (a) to (d)   Article 6(2), points (a) to (d)   Article 4(1), first subparagraph   Article 8(1)   Article 4(1), second subparagraph   Article 8(2)   Article 4(1), third subparagraph   —   Article 4(2)   Article 8(3)   Article 4(3)   Article 8(4)   Article 4(4)   Article 8(5)   Article 4(5), first subparagraph   Article 8(6)   Article 4(5), second subparagraph   Article 8(7)   Article 4a   Article 7   Article 4b   Article 5   Article 5, first paragraph, points (a) to (d)   Article 10, points (a) to (d)   Article 5, first paragraph, point (e)   Article 11(1) and (2)   Article 5, second paragraph   —   Article 5a, first paragraph   Article 11(3)   Article 5a, second paragraph   Article 11(4)   Article 5a, third paragraph   Article 11(5)   Article 6(1), first subparagraph   Article 12(1)   Article 6(1), second subparagraph   Article 12(2)   Article 6(1), third subparagraph   Article 3(3)   Article 6(2), first subparagraph   Article 12(3)   Article 6(2), second subparagraph   Article 12(4)   Article 6(3)   Article 12(5)   — — Article 12(6)   Article 6(4)   —   Article 7     Article 5(2) Article 8(1)     Article 2(3) Article 8(2)     Article 4(3) Article 8(3)     Article 4(2) Article 8(4)     Article 4(3) Article 8a     Article 2(1) and Article 4(1) Article 9(1), first subparagraph     Article 13(1) Article 9(1), second subparagraph     Article 13(2) Article 9(1), third subparagraph     — Article 9(1), fourth subparagraph     — Article 9(1), fifth subparagraph     — Article 9(2),first subparagraph     Article 6(1) Article 9(2), second subparagraph, points (a), (b) and (c)     Article 6(2), points (a), (b) and (c) Article 9(2), third subparagraph   Article 9   —     Article 6(3) Article 10, first paragraph, introductory sentence     Article 14 Article 10, first paragraph, points (a) to (d), and second paragraph     — Article 10a     Article 14 Annex I   —   Annex II   —     Article 1(1) Article 2(1), points (a) and (b)     Article 1(2) Article 2(1), point (c)     Article 1(3) Article 2(1), point (d)     Article 1(4) Article 2(1), point (e)     Article 1(5) Article 2(1), point (f)     Article 1(6) Article 2(1), point (g)     Article 1(7) Article 2(1), point (h)   — — Article 2(2)   — — Article 3(1) and (2)     Article 2(1)   Article 7   Article 2(1), point (a)   Annex I, point 1   Article 2(1), point (b)   Annex I, point 2   Article 2(1), point (c)   —   Article 2(1), point (d)   —   Article 2(1), point (e)   Annex I, point 3   Article 2(1), point (f)   Annex I, point 4   Article 2(1), point (g)   Annex I, point 6   Article 2(1), point (h)   —   Article 2(1), point (i)   Annex I, point 5   Article 2(1), point (j)   Annex I, point 9   Article 2(1), point (k)   Annex I, point 10   Article 2(1), point (l)   Annex I, point 8   Article 2(1), point (m)   Annex I, point 7   Article 2(2), first subparagraph and part of point 9.4 of Annex XII   Article 10(1)   Article 2(2), second subparagraph   Article 11(1)   Article 2(2), third subparagraph   Article 11(2)   —   Article 11(3)   part of point 9.4 of Annex XII   Article 11(4)   Article 2(3), first subparagraph   Article 3(1)   Article 2(3), second subparagraph   Article 3(2)   Article 2(4), first subparagraph   Article 9(2)   Article 2(4), second subparagraph   Article 9(3)   Article 2(4), third subparagraph   Article 9(4)   Article 2(5)   Article 9(5)   Article 2a(1)   Article 3(1)   Article 2a(2)   Article 3(3)   Article 2a(3)   Article 3(4)   Article 2a(4), first subparagraph   Article 3(5)   Article 2a(4), second subparagraph   Article 3(2)   Article 2a(5)   Article 9(1)   Article 3, first paragraph   Article 13(1)   Article 3, second paragraph   Article 3(6)   Article 4(1), first subparagraph   Article 10(1)   Article 4(1), second subparagraph   Article 10(2)   Article 4(1), third subparagraph   Article 10(3)   Article 4(2)   Article 10(4)   Article 4(3)   -   Article 6(1)   Article 12(1)   Article 6(2)   Article 12(2)   Article 7   —   Article 7a, first subparagraph   Article 5(1)   Article 7a, second paragraph   Article 2(2)   Article 8(1)   —   Article 8(2)   Article 14   Annex I Annex I     Annex XII, point 3.3 Annex II     Annex Ia, except for point 2.1   Annex II   Annex Ia, point 2.1   Article 9(6)   Annex Ib   Annex III   Annex III   —   Annex IV   —   Annex VII   —   Annex IX   —   Annex X   —   Annex XI   —   Annex XII, except for point 3.3 and part of point 9.4   —   Annex XV   Annex IV   Annex XVI   —   Annex XVII   —   Annex XVIII   —   Annex XIX   —   Annex XX   —   Annex XXI   Annex V ’

Other acts of the same type
Commission Delegated Regulation (EU) 2022/954 of 12 May 2022 amending the regulatory technical standards laid down in Delegated Regulation (EU) No 183/2014 as regards the specification of the calculation of specific and general credit risk adjustments (Text with EEA relevance)Commission Regulation (EU) 2022/727 of 11 May 2022 refusing to authorise a health claim made on foods and referring to the reduction of disease risk (Text with EEA relevance)Commission Regulation (EU) 2022/719 of 10 May 2022 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)Commission Regulation (EU) 2022/720 of 10 May 2022 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to categories of vertical agreements and concerted practices (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/721 of 10 May 2022 correcting the Czech language version of the Annex to Regulation (EU) No 1300/2014 on the technical specifications for interoperability relating to accessibility of the Union’s rail system for persons with disabilities and persons with reduced mobility (Text with EEA relevance)Commission Regulation (EU) 2022/709 of 6 May 2022 refusing to authorise a health claim made on foods and referring to children’s development and health (Text with EEA relevance)Commission Regulation (EU) 2022/710 of 6 May 2022 refusing to authorise a health claim made on foods and referring to the reduction of disease risk (Text with EEA relevance)Commission Regulation (EU) 2022/711 of 6 May 2022 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/730 of 6 May 2022 entering a name in the register of protected designations of origin and protected geographical indications (‘Wrångebäcksost’ (PDO))Commission Implementing Regulation (EU) 2022/702 of 5 May 2022 concerning the authorisation of great mullein tincture as a feed additive for certain animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/703 of 5 May 2022 concerning the renewal of the authorisation of a preparation of Bacillus velezensis DSM 15544 as a feed additive for weaned piglets, the authorisation for all avian species and categories, amending Implementing Regulation (EU) 2016/897, Implementing Regulation (EU) 2017/2312 and Implementing Regulation (EU) 2018/1081 and repealing Regulation (EU) No 333/2010, Regulation (EU) No 184/2011 and Implementing Regulation (EU) 2019/893 (holder of the authorisation: Asahi Biocycle Co. Ltd., represented in the Union by Pen & Tec Consulting S.L.U.) (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/704 of 5 May 2022 amending and correcting certain Annexes to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries authorised for the entry into the Union of consignments of poultry, germinal products of poultry and fresh meat of poultry and game birds (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next